Literature DB >> 20386014

Importance of distinguishing supported and unsupported off-label drug use.

Surrey M Walton, Glen T Schumock, G Caleb Alexander, David Meltzer, Randall S Stafford.   

Abstract

Mesh：

Year:  2010        PMID： 20386014     DOI： 10.1001/archinternmed.2010.69

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN： 0003-9926


× No keyword cloud information.
  4 in total

1.  The prevalence and cost of unapproved uses of top-selling orphan drugs.

Authors:  Aaron S Kesselheim; Jessica A Myers; Daniel H Solomon; Wolfgang C Winkelmayer; Raisa Levin; Jerry Avorn
Journal:  PLoS One       Date:  2012-02-21       Impact factor: 3.240

Review 2.  Use of contrast media in diagnostic imaging: medico-legal considerations.

Authors:  C Pomara; N Pascale; F Maglietta; M Neri; I Riezzo; E Turillazzi
Journal:  Radiol Med       Date:  2015-06-17       Impact factor: 3.469

Review 3.  Radiographic and magnetic resonances contrast agents: Essentials and tips for safe practices.

Authors:  Mohamed R Nouh; Mohamed A El-Shazly
Journal:  World J Radiol       Date:  2017-09-28

4.  Methods to identify and prioritize patient-centered outcomes for use in comparative effectiveness research.

Authors:  Evan Mayo-Wilson; Asieh Golozar; Terrie Cowley; Nicole Fusco; Gillian Gresham; Jennifer Haythornthwaite; Elizabeth Tolbert; Jennifer L Payne; Lori Rosman; Susan Hutfless; Joseph K Canner; Kay Dickersin
Journal:  Pilot Feasibility Stud       Date:  2018-06-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.